loader image
Saturday, December 20, 2025
70.5 F
McAllen
- Advertisement -

Severe Cases of COVID-19 can Impact the Kidneys

Translate to Spanish or other 102 languages!

The kidneys play an important role in your body, helping with things like filtering your blood and making red blood cells. Image for illustration purposes
The kidneys play an important role in your body, helping with things like filtering your blood and making red blood cells. Image for illustration purposes

Mega Doctor News

- Advertisement -

CLEVELAND CLINIC – The kidneys play an important role in your body, helping with things like filtering your blood and making red blood cells.

And with COVID-19 continuing to spread, the virus can put them at risk.

“Most of the time when someone gets COVID and they have chronic conditions, they end up in the hospital and their respiratory issues get worse, that is when the kidneys get involved,” explained Savag Demirjian, MD, kidney specialist for Cleveland Clinic.

- Advertisement -

Dr. Demirjian said the kidneys can be impacted in a number of ways depending on the severity of COVID-19 illness.

For example, in a more extreme case, someone could suffer permanent kidney damage and may need dialysis. However, in other situations, they could have short-term stress on their kidneys, which can heal with time. In mild to moderate cases of COVID-19, they don’t suspect kidneys are affected.

With that being said, all of this can be avoided if you take the right steps for prevention and get vaccinated.

“If you follow the thought process that the kidneys often are involved when things are progressing to the worse, so anything that sort of stops that cycle from happening, can actually protect the kidneys,” said Dr. Demirjian.

- Advertisement -

He said if you recently recovered from COVID-19 and are noticing some issues with your kidneys, like not urinating enough, have swelling in your legs or are experiencing tiredness, you should consult with your physician. They can then decide the best course of treatment.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

FDA Approves Daily Pill to Treat Low Libido in Women After Menopause

On December 15, 2025, the U.S. Food and Drug Administration (FDA) approved the medication Addyi (flibanserin) for the treatment of hypoactive sexual desire disorder (HSDD) in postmenopausal women under the age of 65.

Heart Association Highlights 2025’s Major Research Findings

In 2025, cardiovascular investigators worldwide reported findings that could help fill important gaps in preventing and managing conditions including high blood pressure, stroke, heart failure, dangerous blood clots and aortic stenosis.

DHR Health and Brownsville Join Forces on Major Hospital Expansion

The City of Brownsville and DHR Health announced a new public-private partnership to expand DHR Health Brownsville, marking a major investment in local healthcare and economic development

Uniting Experts to Revolutionize Cancer Treatment

More than 70% of all cancers are impacted by mutations caused by a group of DNA-editing enzymes that drives tumor growth and drug resistance. The apolipoprotein B mRNA-editing enzyme catalytic polypeptide, or APOBEC, family, is a dominant factor in many cancers including bladder, breast, cervical, head and neck and lung.
- Advertisement -
×